v3.26.1
Condensed Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (8,057) $ (22,930)
Adjustments to reconcile net loss to net cash used for operating activities:    
Depreciation, amortization, and impairment 113 139
Share-based compensation 2,318 1,587
Issuance of warrants 916 0
Amortization of debt issuance costs and discounts 2,286 2,750
Other, net 6 46
Changes in operating assets and liabilities:    
Trade and other receivables, net 10,896 (3,129)
Inventories (1,896) (1,154)
Prepaid expenses and other assets (340) 423
Accounts payable (17,973) 1,905
Accrued expenses and other liabilities (2,803) (2,776)
Deferred revenue (272) (261)
Net cash used for operating activities (14,806) (23,400)
Investing activities:    
Capital expenditures (52) (135)
Net cash used for investing activities (52) (135)
Financing activities:    
Proceeds from common stock issued under public equity offering-ATM, net 4,759 21,360
Proceeds from exercise of stock options, net 1 0
Repayment of debt principal including lease liabilities (8) (6)
Payments for royalty obligations 0 (5)
Payments for taxes on share-based compensation, net (329) (703)
Net cash provided by financing activities 4,423 20,646
Net increase in cash and cash equivalents (10,435) (2,889)
Cash and cash equivalents:    
Cash and cash equivalents at beginning of period 121,169 71,546
Cash and cash equivalents at end of period 110,734 68,657
Supplemental disclosures of cash flow information:    
Cash payments for interest 1,524 1,525
Costs associated with public offering-ATM in Accounts Payable $ 0 $ 89